{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:33:25Z","timestamp":1767155605580,"version":"build-2238731810"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015084","name":"Lung Foundation Netherlands","doi-asserted-by":"publisher","award":["4.1.16.085"],"award-info":[{"award-number":["4.1.16.085"]}],"id":[{"id":"10.13039\/501100015084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study evaluates to what extent symptoms are present before, during, and after a positive SARS-CoV-2 polymerase chain reaction (PCR) test, and to evaluate how the symptom burden and quality of Life (QoL) compares to those with a negative PCR test. Participants from the Dutch Lifelines COVID-19 Cohort Study filled-out as of March 2020 weekly, later bi-weekly and monthly, questions about demographics, COVID-19 diagnosis and severity, QoL, and symptoms. The study population included those with one positive or negative PCR test who filled out two questionnaires before and after the test, resulting in 996 SARS-CoV-2 PCR positive and 3978 negative participants. Nearly all symptoms were more often reported after a positive test\n                    <jats:italic>versus<\/jats:italic>\n                    the period before the test (p\u2009&lt;\u20090.05), except fever. A higher symptom prevalence after\n                    <jats:italic>versus<\/jats:italic>\n                    before a test was also found for nearly all symptoms in negatives (p\u2009&lt;\u20090.05). Before the test, symptoms were already partly present and reporting of nearly all symptoms before did not differ between positives and negatives (p\u2009&gt;\u20090.05). QoL decreased around the test for positives and negatives, with a larger deterioration for positives. Not all symptoms after a positive SARS-CoV-2 PCR test might be attributable to the infection and symptoms were also common in negatives.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-38223-5","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T06:02:28Z","timestamp":1689832948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Symptoms and quality of life before, during, and after a SARS-CoV-2 PCR positive or negative test: data from Lifelines"],"prefix":"10.1038","volume":"13","author":[{"given":"Yvonne M. J.","family":"Go\u00ebrtz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn A.","family":"Spruit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Van Herck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Dukers-Muijrers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Lifelines Corona Research Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Marike","family":"Boezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen O.","family":"Mierau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Lude","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Dekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Deelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Lanting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilja","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil P. S.","family":"Ori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annique","family":"Claringbould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floranne","family":"Boulogne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein X. L.","family":"Dijkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry H.","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Warmerdam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soesma A.","family":"Jankipersadsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"van Blokland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cisca","family":"Wijmenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla J. H.","family":"van der Kallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Burtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy J. A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"38223_CR1","doi-asserted-by":"publisher","first-page":"m1985","DOI":"10.1136\/bmj.m1985","volume":"369","author":"AB Docherty","year":"2020","unstructured":"Docherty, A. B. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ 369, m1985 (2020).","journal-title":"BMJ"},{"key":"38223_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"38223_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","volume":"20","author":"R Verity","year":"2020","unstructured":"Verity, R. et al. Estimates of the severity of coronavirus disease 2019: A model-based analysis. Lancet Infect. Dis. 20, 669\u2013677 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"38223_CR4","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO","year":"2020","unstructured":"WHO. Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"38223_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec, A., Bernabei, R. & Landi, F. Persistent symptoms in patients after acute COVID-19. JAMA 324, 603\u2013605 (2020).","journal-title":"JAMA"},{"key":"38223_CR6","doi-asserted-by":"publisher","first-page":"00141","DOI":"10.1183\/23120541.00141-2021","volume":"7","author":"AW Vaes","year":"2021","unstructured":"Vaes, A. W. et al. Recovery from COVID-19: A sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 7, 00141\u201302021 (2021).","journal-title":"ERJ Open Res."},{"key":"38223_CR7","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).","journal-title":"EClinicalMedicine"},{"key":"38223_CR8","doi-asserted-by":"publisher","first-page":"00542","DOI":"10.1183\/23120541.00542-2020","volume":"6","author":"YMJ Go\u00ebrtz","year":"2020","unstructured":"Go\u00ebrtz, Y. M. J. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome?. ERJ Open Res. 6, 00542\u201302020 (2020).","journal-title":"ERJ Open Res."},{"key":"38223_CR9","doi-asserted-by":"publisher","first-page":"113426","DOI":"10.1016\/j.socscimed.2020.113426","volume":"268","author":"F Callard","year":"2021","unstructured":"Callard, F. & Perego, E. How and why patients made long Covid. Soc. Sci. Med. 268, 113426 (2021).","journal-title":"Soc. Sci. Med."},{"key":"38223_CR10","unstructured":"WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1376291\/retrieve (Accessed 6 October 2021)."},{"key":"38223_CR11","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.3390\/jcm9123993","volume":"9","author":"R Meys","year":"2020","unstructured":"Meys, R. et al. Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J. Clin. Med. 9, 3993 (2020).","journal-title":"J. Clin. Med."},{"key":"38223_CR12","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.3390\/ijerph18116017","volume":"18","author":"JM Delbressine","year":"2021","unstructured":"Delbressine, J. M. et al. The impact of post-COVID-19 syndrome on self-reported physical activity. Int. J. Environ. Res. Public Health 18, 6017 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"38223_CR13","doi-asserted-by":"publisher","first-page":"11647","DOI":"10.1038\/s41598-022-15727-0","volume":"12","author":"Q Wu","year":"2022","unstructured":"Wu, Q., Ailshire, J. & Crimmins, E. Long COVID and symptom trajectory in a representative sample of Americans. Sci. Rep. 12, 11647 (2022).","journal-title":"Sci. Rep."},{"key":"38223_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","volume":"398","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 398, 747\u2013758 (2021).","journal-title":"Lancet"},{"key":"38223_CR15","doi-asserted-by":"publisher","first-page":"e0256142","DOI":"10.1371\/journal.pone.0256142","volume":"16","author":"A S\u00f8raas","year":"2021","unstructured":"S\u00f8raas, A. et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS One 16, e0256142 (2021).","journal-title":"PLoS One"},{"key":"38223_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41591-021-01402-w","volume":"27","author":"Z Amin-Chowdhury","year":"2021","unstructured":"Amin-Chowdhury, Z. & Ladhani, S. N. Causation or confounding: Why controls are critical for characterizing long COVID. Nat. Med. 27, 1129\u20131130 (2021).","journal-title":"Nat. Med."},{"key":"38223_CR17","doi-asserted-by":"publisher","first-page":"100363","DOI":"10.1016\/j.lanepe.2022.100363","volume":"17","author":"O Robineau","year":"2022","unstructured":"Robineau, O. et al. Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: A nested survey in a population-based cohort. Lancet Reg. Health Eur. 17, 100363 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"38223_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/vaccines10050652","volume":"10","author":"WD Strain","year":"2022","unstructured":"Strain, W. D. et al. The impact of COVID vaccination on symptoms of long COVID: An international survey of people with lived experience of long COVID. Vaccines 10, 652 (2022).","journal-title":"Vaccines"},{"key":"38223_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2022.04.013","volume":"103","author":"M Taquet","year":"2022","unstructured":"Taquet, M., Dercon, Q. & Harrison, P. J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 103, 154\u2013162 (2022).","journal-title":"Brain Behav. Immun."},{"key":"38223_CR20","doi-asserted-by":"publisher","first-page":"e007004","DOI":"10.1136\/bmjgh-2021-007004","volume":"6","author":"DA Brown","year":"2021","unstructured":"Brown, D. A. & O\u2019Brien, K. K. Conceptualising long COVID as an episodic health condition. BMJ Glob. Health 6, e007004 (2021).","journal-title":"BMJ Glob. Health"},{"key":"38223_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","volume":"23","author":"RP Stolk","year":"2008","unstructured":"Stolk, R. P. et al. Universal risk factors for multifactorial diseases: LifeLines: A three-generation population-based study. Eur. J. Epidemiol. 23, 67\u201374 (2008).","journal-title":"Eur. J. Epidemiol."},{"key":"38223_CR22","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/ije\/dyu229","volume":"44","author":"S Scholtens","year":"2015","unstructured":"Scholtens, S. et al. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int. J. Epidemiol. 44, 1172\u20131180 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"38223_CR23","doi-asserted-by":"publisher","first-page":"e0137203","DOI":"10.1371\/journal.pone.0137203","volume":"10","author":"B Klijs","year":"2015","unstructured":"Klijs, B. et al. Representativeness of the LifeLines Cohort Study. PLoS One 10, e0137203 (2015).","journal-title":"PLoS One"},{"key":"38223_CR24","doi-asserted-by":"publisher","first-page":"e044474","DOI":"10.1136\/bmjopen-2020-044474","volume":"11","author":"K Mc Intyre","year":"2021","unstructured":"Mc Intyre, K. et al. Lifelines COVID-19 cohort: Investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohort. BMJ Open 11, e044474 (2021).","journal-title":"BMJ Open"},{"key":"38223_CR25","unstructured":"International Standard Classification of Education ISCED. http:\/\/uis.unesco.org\/sites\/default\/files\/documents\/international-standard-classification-of-education-isced-2011-en.pdf (Accessed 6 October 2011)."},{"key":"38223_CR26","doi-asserted-by":"publisher","first-page":"110229","DOI":"10.1016\/j.jpsychores.2020.110229","volume":"137","author":"A Penson","year":"2020","unstructured":"Penson, A. et al. Short fatigue questionnaire: Screening for severe fatigue. J. Psychosom. Res. 137, 110229 (2020).","journal-title":"J. Psychosom. Res."}],"updated-by":[{"DOI":"10.1038\/s41598-024-58848-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38223-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38223-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38223-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T05:05:28Z","timestamp":1712725528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38223-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38223"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38223-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-58848-4","URL":"https:\/\/doi.org\/10.1038\/s41598-024-58848-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.M.J.G., M.V.H., N.D., C.J.H.K., and C.B., have nothing to disclose. M.A.S. reports grants from Lung Foundation Netherlands, Stichting Astma Bestrijding, Boehringer Ingelheim, AstraZeneca, Chiesi and TEVA, outside the submitted work. D.J.A.J. reports grants from the Netherlands Organisation for Health Research and Development (ZonMw), Stichting Astmabestrijding, and the Netherlands Respiratory Society, fees from Boehringer Ingelheim, Chiesi and Abbott, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11713"}}